Zurzuvae: payments to doctors
Payments that named Zurzuvae as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.8M
- Providers
- 18,765
- Transactions
- 53,871
- Average per transaction
- $52
The per-transaction average — $52 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 18,765 providers the average total is $149, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Biogen | $2,150,131 | 76.8% |
| Sage Therapeutics, LLC | $368,503 | 13.2% |
| Sage Therapeutics, Inc. | $279,495 | 10.0% |